Gabriele De Marco Selected Research

Gabriele De Marco Research Topics

9	COVID-19 05/2024 - 01/2021
3	Synovitis 01/2021 - 01/2016
2	Rheumatic Diseases (Rheumatism) 05/2024 - 11/2023
2	Inflammation (Inflammations) 01/2021 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2006
2	Psoriatic Arthritis 01/2021 - 07/2017
2	Necrosis 11/2018 - 04/2015
2	Pain (Aches) 01/2018 - 01/2010
1	Axial Spondyloarthritis 03/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 07/2022
1	Autoimmune Diseases (Autoimmune Disease) 07/2022
1	Vasculitis (Vasculitides) 01/2022
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 01/2022
1	Communicable Diseases (Infectious Diseases) 04/2021
1	Stroke (Strokes) 01/2021
1	Thromboinflammation 01/2021
1	Infections 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Enthesopathy 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Ankylosing Spondylitis 04/2015
1	Rheumatoid Arthritis 10/2010
1	Macrophage Activation Syndrome 10/2010
1	Back Pain (Backache) 01/2010
1	Headache (Headaches) 01/2006
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2006
1	Crohn Disease (Crohn's Disease) 01/2006

5	VaccinesIBA 05/2024 - 01/2021
4	InterferonsIBA 05/2024 - 01/2021
3	Immunologic Factors (Immunomodulators)IBA 01/2022 - 01/2021
3	GlucocorticoidsIBA 01/2022 - 01/2021
2	Antirheumatic Agents (DMARD)IBA 03/2023 - 01/2021
2	AutoantibodiesIBA 07/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 01/2021
2	baricitinibIBA 01/2022 - 10/2021
2	tofacitinibIBA 01/2022 - 10/2021
2	tocilizumab (atlizumab)FDA Link 01/2022 - 10/2021
2	Janus Kinase InhibitorsIBA 01/2022 - 10/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2021
2	Immunomodulating AgentsIBA 10/2021 - 01/2021
2	CytokinesIBA 01/2021 - 11/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2016
1	mRNA VaccinesIBA 11/2023
1	Nucleic AcidsIBA 07/2022
1	RNA (Ribonucleic Acid)IBA 07/2022
1	AntigensIBA 07/2022
1	COVID-19 VaccinesIBA 07/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	DNA VaccinesIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Viral RNAIBA 01/2021
1	AntibodiesIBA 01/2021
1	amsonic acid (DAS)IBA 01/2020
1	apremilastIBA 01/2020
1	Interleukin-12 (IL 12)IBA 11/2018
1	golimumab FDA Link 07/2017
1	Methotrexate (Mexate)FDA LinkGeneric 07/2017
1	Leflunomide (Arava)FDA LinkGeneric 10/2010
1	Alkaline PhosphataseIBA 01/2010
1	Etanercept (Enbrel)FDA Link 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006